J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, W.-H.
Right arrow Articles by Shimamura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, W.-H.
Right arrow Articles by Shimamura, T.
Agricola
Right arrow Articles by Zhao, W.-H.
Right arrow Articles by Shimamura, T.
J Med Microbiol 57 (2008), 974-979; DOI: 10.1099/jmm.0.2008/001388-0
© 2008 Society for General Microbiology
ISSN 1473-5644

Potency of IMP-10 metallo-β-lactamase in hydrolysing various antipseudomonal β-lactams

Wei-Hua Zhao, Zhi-Qing Hu and Tadakatsu Shimamura

Department of Microbiology and Immunology, Showa University School of Medicine, Tokyo 142-8555, Japan

Correspondence
Wei-Hua Zhao
whzhao{at}med.showa-u.ac.jp

Received 19 February 2008
Accepted 31 March 2008

Limited β-lactams show antipseudomonal activity. The rapid spread of IMP-type metallo-β-lactamases (MBLs), which have a broad spectrum of substrates and a poor susceptibility to clinically available inhibitors, further restricts β-lactam use. In the present study, we evaluated the potency of IMP-10 MBL in hydrolysing antipseudomonal β-lactams currently available in the clinic. Crude IMP-10 MBL was prepared from two clinical isolates of Pseudomonas aeruginosa harbouring the blaIMP-10 gene. The sensitivity of β-lactams to hydrolysis by IMP-10 MBL was determined by comparing the MICs of 14 antipseudomonal β-lactams against a susceptible strain of P. aeruginosa in the presence and absence of IMP-10 MBL. Carbapenems (imipenem, meropenem and panipenem) and extended-spectrum cephems (ceftazidime, cefoperazone, cefsulodin and cefepime) were sensitive to the hydrolysing activity of IMP-10 MBL. By comparison, the fourth-generation cephem (cefpirome), the extended-spectrum penicillins (carbenicillin, ticarcillin, piperacillin and mezlocillin) and monobactams (aztreonam and carumonam) were relatively resistant to IMP-10 MBL. The sensitivity profile of antipseudomonal β-lactams to IMP-10 MBL generated in the present study provides a valuable reference for antibiotic selection by medical professionals.

Abbreviations: AZT, aztreonam; CAZ, ceftazidime; CBPC, carbenicillin; CFPM, cefepime; CFS, cefsulodin; CPR, cefpirome; CPZ, cefoperazone; CRMN, carumonam; IPM, imipenem; MBL, metallo-β-lactamase; MEPM, meropenem; MZPC, mezlocillin; PAPM, panipenem; PCase, penicillinase; PIPC, piperacillin; TIPC, ticarcillin.




This article has been cited by other articles:


Home page
 J Med MicrobiolHome page
Z. Hu and W.-H. Zhao
Identification of plasmid- and integron-borne blaIMP-1 and blaIMP-10 in clinical isolates of Serratia marcescens
J. Med. Microbiol., February 1, 2009; 58(2): 217 - 221.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2008 Society for General Microbiology.